Clinical trial
A Phase 2, Multicentre, Open-Label Trial to Evaluate APL-9796 in Adult Participants With Pulmonary Hypertension (ViTAL-PH)
NCT06846554 is registered in ClinicalTrials.gov with Apollo Therapeutics Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Multicentre, Open-Label Trial to Evaluate APL-9796 in Adult Participants With Pulmonary Hypertension (ViTAL-PH)
- Lead sponsor
- Apollo Therapeutics Ltd
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- April 9, 2025
- Completion date
- September 30, 2027
- Enrollment
- 48 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.